Estrogen hormone therapy and postmenopausal osteoporosis: does it really take two to tango?

被引：1
|
作者：
Silva, Barbara Campolina [1 ]
Rodrigues, Marcio Alexandre Hipolito [2 ,3 ]
机构：
[1] Santa Casa Hosp, Endocrinol Unit, Belo Horizonte, Brazil
[2] Univ Fed Minas Gerais, Sch Med, Obstet & Gynecol Dept, Belo Horizonte, Brazil
[3] Hosp Cochin, Endocrine Gynecol Unit, Paris, France
来源：
WOMEN & HEALTH | 2023年 / 63卷 / 10期
关键词：
BONE-MINERAL DENSITY; PLUS PROGESTIN; HEALTH; RISK; MANAGEMENT; FRACTURE; WOMEN;
D O I：
10.1080/03630242.2023.2278211
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：770 / 773
页数：4
相关论文
共 50 条
  • [21] Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management : CNGOF and GEMVi clinical practice guidelines
    Pouilles, J-M
    Gosset, A.
    Tremollieres, F.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2021, 49 (05): : 420 - 437
  • [22] Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis.: Effect of adding hormone replacement therapy
    Cortet, B
    Béra-Louville, A
    Gauthier, P
    Gauthier, A
    Marchandise, X
    Delcambre, B
    JOINT BONE SPINE, 2001, 68 (05) : 410 - 415
  • [23] Breast cancer after hormone replacement therapy - does prognosis differ in perimenopausal and postmenopausal women?
    Baumgaertner, A. K.
    Haeusler, A.
    Seifert-Klauss, V.
    Schuster, T.
    Schwarz-Boeger, U.
    Kiechle, M.
    BREAST, 2011, 20 (05) : 448 - 454
  • [24] Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer
    Cerne, Jasmina Ziva
    Novakovic, Srdjan
    Frkovic-Grazio, Snjezana
    Pohar-Perme, Maja
    Stegel, Vida
    Gersak, Ksenija
    ONCOLOGY REPORTS, 2011, 26 (02) : 479 - 485
  • [25] Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women
    van Amelsvoort, T
    Murphy, DGM
    Robertson, D
    Daly, E
    Whitehead, M
    Abel, K
    PSYCHONEUROENDOCRINOLOGY, 2003, 28 (01) : 101 - 112
  • [26] Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens
    Scarabin, Pierre-Yves
    Hemker, H. Coen
    Clement, Celine
    Soisson, Veronique
    Alhenc-Gelas, Martine
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (08): : 873 - 879
  • [27] CYP2C19 Genotype and Proton Pump Inhibitors in Clopidogrel-Treated Patients Does It Take Two to Tango?
    O'Donoghue, Michelle L.
    CIRCULATION, 2011, 123 (05) : 468 - 470
  • [28] Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study
    Tiras, MB
    Noyan, V
    Yildiz, A
    Yildirim, M
    Daya, S
    HUMAN REPRODUCTION, 2000, 15 (10) : 2087 - 2092
  • [29] Does hormone therapy counter the beneficial effects of physical activity on breast cancer risk in postmenopausal women?
    Dieli-Conwright, Christina M.
    Sullivan-Halley, Jane
    Patel, Alpa
    Press, Michael
    Malone, Kathleen
    Ursin, Giske
    Burkman, Ronald
    Strom, Brian
    Simon, Michael
    Weiss, Linda
    Marchbanks, Polly
    Folger, Suzanne
    Spirtas, Robert
    Deapen, Dennis
    Bernstein, Leslie
    CANCER CAUSES & CONTROL, 2011, 22 (03) : 515 - 522
  • [30] The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor α genotype in early postmenopausal women
    Salmén, T
    Heikkinen, AM
    Mahonen, A
    Kröger, H
    Komulainen, M
    Saarikoski, S
    Honkanen, R
    Mäenpää, PH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (12) : 2479 - 2486
12345